Literature DB >> 17483071

Insulin-like growth factor-binding protein 3 and hemoglobin concentration in older persons living in the community.

Francesco Landi1, Andrea Russo, Ettore Capoluongo, Matteo Cesari, Rosa Liperoti, Paola Danese, Roberto Bernabei, Graziano Onder.   

Abstract

A decreased hemoglobin concentration is a common clinical condition in elderly subjects, and in at least 20% of the cases it is not possible to directly attribute the anemia to specific factors. The aim of the present study was to evaluate the relationship of different levels of insulin-like growth factor-binding protein 3 (IGFBP-3) with the blood concentration of hemoglobin in persons aged 80 years and older. Data are from a baseline evaluation of the Aging and Longevity in the Sirente Geographic Area (ilSIRENTE) study (n=253). Analysis of covariance was used to examine the effect of different IGFBP-3 levels on hemoglobin concentration. After adjustment for potential confounding variables, which included age, sex, number of diseases, renal failure, cancer, gastric ulcer, albumin, and iron concentrations, individuals in the group with higher IGFBP-3 concentrations showed a significantly higher mean hemoglobin concentration than participants in the group with lower IGFBP-3 concentrations (13.4 +/- 1.4 g/dL versus 12.9 +/- 1.9 g/dL, respectively; P=.03). In conclusion, the present study has shown that a higher IGFBP-3 level is associated with a higher hemoglobin concentration among older people living in the community. This finding suggests that the growth hormone/IGF axis may play an important role in hematopoiesis, and it may be implicated in the age-related decline in hemoglobin concentration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483071     DOI: 10.1532/IJH97.E0629

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  38 in total

1.  Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects.

Authors:  Herman Nilsson-Ehle; Bengt-Ake Bengtsson; Göran Lindstedt; Dan Mellström
Journal:  Eur J Haematol       Date:  2005-02       Impact factor: 2.997

2.  Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution.

Authors:  Richard A French; Suzanne R Broussard; William A Meier; Christian Minshall; Sean Arkins; James F Zachary; Robert Dantzer; Keith W Kelley
Journal:  Endocrinology       Date:  2002-02       Impact factor: 4.736

3.  Anemia and hemoglobin levels in older persons: relationship with age, gender, and health status.

Authors:  M E Salive; J Cornoni-Huntley; J M Guralnik; C L Phillips; R B Wallace; A M Ostfeld; H J Cohen
Journal:  J Am Geriatr Soc       Date:  1992-05       Impact factor: 5.562

4.  Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells.

Authors:  S L Abboud; C R Bethel; D C Aron
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

5.  The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.

Authors:  E R Christ; M H Cummings; N B Westwood; B M Sawyer; T C Pearson; P H Sönksen; D L Russell-Jones
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

6.  Association of serum insulin-like growth factor-I and erythropoiesis in relation to body iron status.

Authors:  Jong Weon Choi; Soon Ki Kim
Journal:  Ann Clin Lab Sci       Date:  2004       Impact factor: 1.256

7.  Comparative studies of the erythroid-potentiating effects of biosynthetic human insulin-like growth factors-I and -II.

Authors:  S Merchav; I Silvian-Drachsler; I Tatarsky; M Lake; A Skottner
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

8.  Insulin-like growth factor I: a modulator of erythropoiesis in uraemic patients?

Authors:  P Ureña; A Bonnardeaux; K U Eckardt; A Kurtz; T B Drüeke
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

9.  Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size.

Authors:  Christian F Singer; Maurice Mogg; Wolfgang Koestler; Margit Pacher; Erika Marton; Ernst Kubista; Martin Schreiber
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

10.  Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.

Authors:  K Sawada; S B Krantz; E N Dessypris; S T Koury; S T Sawyer
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

View more
  3 in total

1.  INSULIN-LIKE GROWTH FACTOR-1 AND ANEMIA IN OLDER SUBJECTS: THE INCHIANTI STUDY.

Authors:  Francesca De Vita; Marcello Maggio; Fulvio Lauretani; Lara Crucitti; Stefania Bandinelli; Federica Mammarella; Francesco Landi; Luigi Ferrucci; Gian Paolo Ceda
Journal:  Endocr Pract       Date:  2015-07-27       Impact factor: 3.443

2.  Maintenance of naïve CD8 T cells in nonagenarians by leptin, IGFBP3 and T3.

Authors:  Jian Chen; Jun Li; Fei Chu Lim; Qi Wu; Daniel C Douek; Donald K Scott; Eric Ravussin; Hui-Chen Hsu; S Michal Jazwinski; John D Mountz
Journal:  Mech Ageing Dev       Date:  2009-11-24       Impact factor: 5.432

Review 3.  The Role of the Multiple Hormonal Dysregulation in the Onset of "Anemia of Aging": Focus on Testosterone, IGF-1, and Thyroid Hormones.

Authors:  Marcello Maggio; Francesca De Vita; Alberto Fisichella; Fulvio Lauretani; Andrea Ticinesi; Graziano Ceresini; Anne Cappola; Luigi Ferrucci; Gian Paolo Ceda
Journal:  Int J Endocrinol       Date:  2015-12-08       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.